The Leo A. Rinke Cancer Research Fund was created to honor Leo who was diagnosed with acute mylegenous leukemia (AML), a cancer of the blood and bone marrow in April 2023. Leo was a generous, humble, and caring man to whom family and friends mean everything. When he was told elsewhere that all hope was lost, he found hope at Karmanos through a compassionate care team and their research trials. Leo, along with his friends and family, are focused on bringing that hope to others through continued research toward a cure for all cancers.